Last update :
27/11/2024
References   References 3632  
Type : Manufacturer

Research teams :
Authors :
Title : Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics
Reference : Hospira 2017

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionEpirubicin hydrochloride Anticancer drug
Factors which affect stability pH pH >7 Induces Degradation
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 2-8°C Not specified
84 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 25 °C Not specified
14 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 2-8°C Not specified
84 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 25 °C Not specified
14 Day
Incompatible + injectionHeparin sodium
Incompatible + injectionSodium bicarbonate
Incompatible + NaHCO3
injectionHeparin sodium Anticoagulant
Incompatible + injectionEpirubicin hydrochloride
injectionSodium bicarbonate Electrolyte
Incompatible + injectionEpirubicin hydrochloride

  Mentions Légales